GOVX - GeoVax Labs, Inc. New

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.6 0.0 (-0.2%)	---	---	0.0 (-0.02%)	0.0 (0.71%)	0.0 (0.3%)	0.0 (-0.02%)	0.0 (-0.02%)

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.35
Diluted EPS:
Basic P/E:: -1.6977
Diluted P/E:
RSI(14) 1m:: 0.0
VWAP:: 0.59
RVol:: 0.4884

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.59 -0.01 (-1.65%)	Oct 15 09:36
1m	Price increase 1m	0.61 +0.01 (+1.65%)	Oct 15 09:30
60m	Price increase 60m	0.61 +0.03 (+5.08%)	Oct 15 09:30
1m	Price increase 1m	0.6 +0.01 (+1.78%)	Oct 15 09:27
1m	Price decrease 1m	0.57 -0.01 (-1.12%)	Oct 15 09:02